NCNO
nCino, Inc.
NCNO's outlook is improving, though it still trails on the overall score.
NVDA
NVIDIA Corporation
NVDA has the edge over NCNO overall, supported by stronger valuation and stronger modeled upside.
NCNO Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Healthy | |
| Strong | |
| Stable |
NCNO's revenue, profitability and cash flow are currently healthy, and its balance sheet is stable.
NVDA Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Strong | |
| Strong | |
| Strong |
NVDA's revenue, profitability, cash flow and balance sheet are all currently strong.
NCNO PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 15x | $22.36 | — |
| Cheap | 72x | $21.56 | -3.6% |
| Current | 75x | $22.36 | — |
| Fair | 133x | $40.02 | +79% |
| Expensive | 333x | $99.88 | +347% |
Historical ranges are pointers, not guarantees.
NCNO's PE is 75x, but its earnings don't support one, so it isn't a reliable read right now.
NVDA PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 12x | $166 | — |
| Current | 21x | $166 | — |
| Cheap | 44x | $345 | +108% |
| Fair | 65x | $511 | +207% |
| Expensive | 93x | $734 | +342% |
Historical ranges are pointers, not guarantees.
NVDA has the edge over NCNO in the historical PE scenario, which offers more potential upside but is not a forecast.
NCNO Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Growth | |
| Strongly improving | |
| Limited | |
| Moderate |
NCNO has the edge over NVDA on the outlook, with more favorable profitability expectations.
NVDA Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Strong growth | |
| Weakening | |
| Broad | |
| Moderate |
Analysts expect strong earnings and revenue growth for NVDA, but weaker profitability.
NCNO Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $1.51 | +405% |
| Q3 2026 | $0.30 | +$0.58 |
| Q2 2026 | $0.12 | +$0.37 |
| Q1 2026 | $0.05 | +$0.38 |
| Q4 2025 | -$0.17 | $0.00 |
| Q3 2025 | -$0.28 | -$0.01 |
| Q2 2025 | -$0.25 | +$0.06 |
| Q1 2025 | -$0.33 | +$0.05 |
| Q4 2024 | -$0.17 | +$0.41 |
NCNO has returned to profit: it earned $0.30 per share over the past year, after losing money the year before.
NVDA Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $13.77 | +74% |
| Q3 2026 | $7.91 | +125% |
| Q2 2026 | $6.53 | +111% |
| Q1 2026 | $4.90 | +67% |
| Q4 2025 | $4.03 | +59% |
| Q3 2025 | $3.51 | +65% |
| Q2 2025 | $3.10 | +81% |
| Q1 2025 | $2.94 | +147% |
| Q4 2024 | $2.54 | +234% |
NVDA has the edge over NCNO on earnings, with more consistent year-over-year improvement.
NCNO Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $161M | +8.2% |
| Q2 2026 | $159.4M | +11% |
| Q1 2026 | $149.7M | +5.9% |
| Q4 2025 | $152.2M | +9.6% |
| Q3 2025 | $148.8M | +12% |
| Q2 2025 | $144.1M | +13% |
| Q1 2025 | $141.4M | +14% |
| Q4 2024 | $138.8M | +14% |
NCNO's revenue has grown year over year every quarter since late 2020: $161M last quarter, up 8.2% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 8.5% | +15 points |
| Q2 2026 | 13% | +14 points |
| Q1 2026 | 1.9% | +5.9 points |
| Q4 2025 | 7.7% | +8.3 points |
| Q3 2025 | -6.3% | -0.3 points |
| Q2 2025 | -1.1% | +1.8 points |
| Q1 2025 | -4.1% | -1.5 points |
| Q4 2024 | -0.6% | +10 points |
NCNO's operating margin was 8.5% last quarter, up 15 points from the same quarter a year ago, near the top of its range since 2019.
NVDA Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $96.2B | +106% |
| Q2 2026 | $81.6B | +85% |
| Q1 2026 | $68.1B | +73% |
| Q4 2025 | $57B | +62% |
| Q3 2025 | $46.7B | +56% |
| Q2 2025 | $44.1B | +69% |
| Q1 2025 | $39.3B | +78% |
| Q4 2024 | $35.1B | +94% |
NVDA has the edge over NCNO on sales, with stronger typical year-over-year growth.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 66% | +5.4 points |
| Q2 2026 | 66% | +17 points |
| Q1 2026 | 65% | +3.9 points |
| Q4 2025 | 63% | +0.8 points |
| Q3 2025 | 61% | -1.2 points |
| Q2 2025 | 49% | -16 points |
| Q1 2025 | 61% | -0.5 points |
| Q4 2024 | 62% | +4.9 points |
NVDA has the edge over NCNO on profitability, with a higher operating margin.
NCNO Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $34M | +170% |
| Q2 2026 | $80.8M | +54% |
| Q1 2026 | $12.5M | +$22.8M |
| Q4 2025 | $4.9M | -3.9% |
| Q3 2025 | $12.6M | +176% |
| Q2 2025 | $52.6M | -2.8% |
| Q1 2025 | -$10.4M | -234% |
| Q4 2024 | $5.1M | -2.9% |
NCNO generated $132M in free cash flow over the past year, up 121% from the year before.
NVDA Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $21.4B | +59% |
| Q2 2026 | $48.6B | +86% |
| Q1 2026 | $34.9B | +124% |
| Q4 2025 | $22.1B | +32% |
| Q3 2025 | $13.5B | -0.3% |
| Q2 2025 | $26.2B | +75% |
| Q1 2025 | $15.6B | +38% |
| Q3 2024 | $13.5B | +113% |
NVDA has the edge over NCNO on cash flow, with more consistent year-over-year improvement.
NCNO Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -3.7% | -4.1M shares |
| 1 year | -8.6% | -9.9M shares |
| 3 years | -6.3% | -7M shares |
| 5 years | +10% | +9.7M shares |
| Available history | +18% | +15.7M shares |
NCNO has the edge over NVDA on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $65.6M |
| Q2 2026 | $110.1M |
| Q1 2026 | $25M |
| Q4 2025 | $39.5M |
| Q3 2025 | $20M |
| Q2 2025 | $40.6M |
| Q1 2022 | — |
| Q4 2021 | — |
NCNO spent $240M buying back its own shares over the past year.
NVDA Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.4% | -106M shares |
| 1 year | -1% | -247M shares |
| 3 years | -2.8% | -705M shares |
| 5 years | -4.1% | -1B shares |
| Available history | -1.8% | -435M shares |
NVDA has 24.3B diluted shares, down 1% from a year ago, with $55.3B in buybacks over the past year.
| Quarter | Spent |
|---|---|
| Q3 2026 | $19.7B |
| Q2 2026 | $19.3B |
| Q1 2026 | $3.8B |
| Q4 2025 | $12.5B |
| Q3 2025 | $9.7B |
| Q2 2025 | $14.1B |
| Q1 2025 | $7.8B |
| Q4 2024 | $11B |
NVDA spent $55.3B buying back its own shares over the past year, up 30% from the year before.
NCNO Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 2.1x | Moderate |
| Q2 2026 | 2.4x | Moderate |
| Q1 2026 | 2.7x | Moderate |
| Q4 2025 | 3.1x | Elevated |
| Q3 2025 | 3.5x | Elevated |
| Q2 2025 | 3.3x | Elevated |
| Q1 2025 | 2.5x | Moderate |
| Q4 2024 | -5.0x | Net Cash |
NCNO's net debt is about 2.1 years of its operating earnings (EBITDA), down from 3.5 years a year ago.
NVDA Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.1x | Very low |
| Q2 2026 | -0.0x | Net Cash |
| Q1 2026 | -0.0x | Net Cash |
| Q4 2025 | -0.0x | Net Cash |
| Q3 2025 | -0.0x | Net Cash |
| Q2 2025 | -0.1x | Net Cash |
| Q1 2025 | -0.0x | Very low |
| Q4 2024 | -0.0x | Net Cash |
NVDA has the edge over NCNO on leverage, with a lower net debt burden relative to earnings.
NCNO Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 58.1 | Neutral |
| Stochastic | 77.0 | Neutral |
NCNO's weekly RSI is 58 (neutral) and its Stochastic is 77 (neutral).
NVDA Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 33.4 | Neutral |
| Stochastic | 18.1 | Oversold |
NVDA's weekly RSI is 33 (neutral) and its Stochastic is 18 (oversold).
NCNO PE vs Technology Sector
| Metric | NCNO | Sector median | Relative |
|---|---|---|---|
| PE | 75x | 28x | 168% above |
| PE % | 19 | 37 | 18 pts below |
NCNO is trading at 75x earnings, a 168% premium to the Technology sector's median of 28x, though its earnings don't support one.
NVDA PE vs Technology Sector
| Metric | NVDA | Sector median | Relative |
|---|---|---|---|
| PE | 21x | 28x | 25% below |
| PE % | 0 | 35 | 35 pts below |
NVDA has the edge over NCNO on valuation relative to its sector.
NCNO Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $21.2 | 5.7% above |
| 20 week MA | $20.3 | 10% above |
| 50 week MA | $19.4 | 15% above |
| 100 week MA | $23.8 | 6.2% below |
| 200 week MA | $27.2 | 18% below |
NCNO has the edge over NVDA on trend strength, trading above more of its moving averages.
NVDA Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $208.9 | 20% below |
| 20 week MA | $212.0 | 22% below |
| 50 week MA | $199.9 | 17% below |
| 100 week MA | $175.1 | 5.1% below |
| 200 week MA | $123.6 | 34% above |
NVDA has fallen below most of its moving averages, though it's still 34% above its 200-week average.
NCNO Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $74.0 | $78.7 | +6.3% |
| 2021 | $78.7 | $57.0 | -28% |
| 2022 | $57.0 | $25.9 | -55% |
| 2023 | $25.9 | $33.6 | +30% |
| 2024 | $33.6 | $34.4 | +2.4% |
| 2025 | $34.4 | $26.3 | -24% |
| 2026 YTD | $26.3 | $22.4 | -15% |
NCNO has finished lower in three of the last six years. It's down 15% so far in 2026.
NVDA Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $5.92 | $13.0 | +119% |
| 2021 | $13.0 | $29.6 | +128% |
| 2022 | $29.6 | $15.2 | -49% |
| 2023 | $15.2 | $49.5 | +226% |
| 2024 | $49.5 | $137.0 | +177% |
| 2025 | $137.0 | $190.5 | +39% |
| 2026 YTD | $190.5 | $166.2 | -13% |
NVDA has the edge over NCNO on returns for 2026, with the stronger performance.